RAMM Pharma Corp.
RAMM
CNSX
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 382.50K | 539.40K | 332.00K | 584.20K | 1.09M |
Total Receivables | 1.13M | 1.16M | 1.20M | 1.18M | 1.21M |
Inventory | 1.15M | 1.41M | 1.39M | 1.82M | 1.96M |
Prepaid Expenses | 12.60K | 12.30K | 12.40K | 185.40K | 94.40K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 52.30K | 57.60K | 145.40K | 73.00K | 129.00K |
Total Current Assets | 2.72M | 3.18M | 3.08M | 3.85M | 4.48M |
|
|||||
Total Current Assets | 2.72M | 3.18M | 3.08M | 3.85M | 4.48M |
Net Property, Plant & Equipment | 8.07M | 8.06M | 7.59M | 8.04M | 13.56M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 3.20K | 22.70K | 75.80K | 134.90K | 192.80K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | 1.60M |
Total Assets | 10.79M | 11.25M | 10.74M | 12.02M | 19.84M |
|
|||||
Total Accounts Payable | 354.50K | 492.50K | 539.10K | 462.40K | 491.40K |
Total Accrued Expenses | 146.10K | 146.90K | 143.30K | 257.00K | 206.10K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 20.10K | 31.30K | 84.00K | 74.30K | 109.80K |
Total Finance Division Other Current Liabilities | 1.31M | 1.37M | 1.34M | 1.38M | 482.40K |
Total Other Current Liabilities | 1.31M | 1.37M | 1.34M | 1.38M | 482.40K |
Total Current Liabilities | 1.83M | 2.04M | 2.10M | 2.17M | 1.29M |
|
|||||
Total Current Liabilities | 1.83M | 2.04M | 2.10M | 2.17M | 1.29M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 52.60K | 60.90K | 69.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.83M | 2.04M | 2.16M | 2.23M | 1.36M |
|
|||||
Common Stock & APIC | 49.10M | 49.17M | 46.88M | 48.69M | 46.36M |
Retained Earnings | -48.89M | -48.59M | -46.25M | -47.30M | -39.43M |
Treasury Stock & Other | 8.76M | 8.63M | 7.95M | 8.39M | 11.55M |
Total Common Equity | 8.96M | 9.22M | 8.59M | 9.78M | 18.48M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 8.96M | 9.22M | 8.59M | 9.78M | 18.48M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 8.96M | 9.22M | 8.59M | 9.78M | 18.48M |
|